Clin Exp Otorhinolaryngol.  2022 Feb;15(1):100-106. 10.21053/ceo.2020.02362.

The Impact of National Health Insurance Coverage on Compliance With Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea

Affiliations
  • 1Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea
  • 2Department of Otorhinolaryngology-Head and Neck Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Abstract


Objectives
. Compliance with positive airway pressure (PAP) in patients with obstructive sleep apnea (OSA) directly affects its treatment efficacy. Since July 2018, polysomnography and PAP therapy have been covered by the National Health Insurance (NHI), which has reduced the price barrier and promoted PAP therapy in Korea. This study aimed to compare changes in PAP compliance before and after NHI implementation.
Methods
. This study is a retrospective analysis in a tertiary hospital setting in Korea. From 2011 to 2019, patients with OSA (apnea-hypopnea index ≥5) treated using a PAP device for ≥1 month were included. They were classified as belonging to the pre-insurance (PI) group (having started PAP before July 2018) or the NHI group (having received a PAP reimbursement by the NHI service). We collected and analyzed medical records and PAP use information for between-group comparisons of compliance. We defined compliance as the percentage of usage days, the percentage of days with usage for ≥4 night hours, and average daily usage hours.
Results
. We included 146 and 100 patients in the PI and NHI groups, respectively. Automatic PAP mode and NHI were independent predictors of compliance B at the 3- and 9-month follow-up points. The NHI group showed significantly higher compliance A at 3, but not 9 months. For compliance B, the NHI group showed significantly higher compliance than the PI group at 1 month and 3 months, but not at 9 months. Compared with the PI group, the NHI group showed significantly higher compliance C only at 3 months.
Conclusion
. The NHI has positively affected PAP therapy in patients with OSA. Insurance policy may affect compliance within the first 3 months of PAP therapy.

Keyword

National Health Insurance; Positive Airway Pressure; Compliance; Obstructive Sleep Apnea

Figure

  • Fig. 1. Proportions of follow-up and adherent patients at 1, 3, and 9 months. PI, pre-insurance; NHI, National Health Insurance. a)Number of follow-up patients out of total number of group patients. b)Number of adherent patients out of total number of group patients.


Reference

1. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981; Apr. 1(8225):862–5.
Article
2. McGinley BM, Schwartz AR, Schneider H, Kirkness JP, Smith PL, Patil SP. Upper airway neuromuscular compensation during sleep is defective in obstructive sleep apnea. J Appl Physiol (1985). 2008; Jul. 105(1):197–205.
Article
3. Antic NA, Catcheside P, Buchan C, Hensley M, Naughton MT, Rowland S, et al. The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA. Sleep. 2011; Jan. 34(1):111–9.
Article
4. McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016; Sep. 375(10):919–31.
Article
5. Lisan Q, Van Sloten T, Marques Vidal P, Haba Rubio J, Heinzer R, Empana JP. Association of positive airway pressure prescription with mortality in patients with obesity and severe obstructive sleep apnea: the sleep heart health study. JAMA Otolaryngol Head Neck Surg. 2019; Jun. 145(6):509–15.
Article
6. Weaver TE, Maislin G, Dinges DF, Bloxham T, George CF, Greenberg H, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep. 2007; Jun. 30(6):711–9.
Article
7. Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis. 1993; Apr. 147(4):887–95.
Article
8. Simon-Tuval T, Reuveni H, Greenberg-Dotan S, Oksenberg A, Tal A, Tarasiuk A. Low socioeconomic status is a risk factor for CPAP acceptance among adult OSAS patients requiring treatment. Sleep. 2009; Apr. 32(4):545–52.
Article
9. Gulati A, Ali M, Davies M, Quinnell T, Smith I. A prospective observational study to evaluate the effect of social and personality factors on continuous positive airway pressure (CPAP) compliance in obstructive sleep apnoea syndrome. BMC Pulm Med. 2017; Mar. 17(1):56.
Article
10. Leemans J, Rodenstein D, Bousata J, Mwenge GB. Impact of purchasing the CPAP device on acceptance and long-term adherence: a Belgian model. Acta Clin Belg. 2018; Feb. 73(1):34–9.
Article
11. Han EK, Yoon IY, Chung SH. The compliance and effect of CPAP in obstructive sleep apnea syndrome. Sleep Med Psychophysiol. 2006; Dec. 13(2):52–8.
12. Lee SM, Lee YJ, Kim JH. Common side effects and compliance with nasal continuous positive airway pressure in Korean OSA patients: short-term follow up. J Korean Sleep Res Soc. 2010; Jun. 7(1):1–7.
Article
13. KIM MJ, Kim MJ, Bae SH, Park CH, Kim DK. Predictors of adherence with positive airway pressure treatment in patients with obstructive sleep apnea in Korean. J Rhinol. 2015; Nov. 22(2):89–95.
Article
14. Kim SL, Kim JA, Kim DS, Jo MG, Kim SD, Cho KS. Effect of doctor and device manager on adherence with positive airway pressure therapy in obstructive sleep apnea patients. J Rhinol. 2018; May. 25(1):26–31.
Article
15. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991; Dec. 14(6):540–5.
Article
16. Naik S, Al-Halawani M, Kreinin I, Kryger M. Centers for Medicare and Medicaid Services positive airway pressure adherence criteria may limit treatment to many Medicare beneficiaries. J Clin Sleep Med. 2019; Feb. 15(2):245–51.
Article
17. Van Ryswyk E, Anderson CS, Antic NA, Barbe F, Bittencourt L, Freed R, et al. Predictors of long-term adherence to continuous positive airway pressure in patients with obstructive sleep apnea and cardiovascular disease. Sleep. 2019; Oct. 42(10):zsz152.
Article
18. Popescu G, Latham M, Allgar V, Elliott MW. Continuous positive airway pressure for sleep apnoea/hypopnoea syndrome: usefulness of a 2 week trial to identify factors associated with long term use. Thorax. 2001; Sep. 56(9):727–33.
Article
19. Billings ME, Kapur VK. Medicare long-term CPAP coverage policy: a cost-utility analysis. J Clin Sleep Med. 2013; Oct. 9(10):1023–9.
Article
20. Ghrairi H, Khalfallah I, Abid N, Loukil M. Adherence to treatment with continuous positive airways pressure. Rev Mal Respir. 2018; May. 35(5):531–7.
21. Sin DD, Mayers I, Man GC, Pawluk L. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest. 2002; Feb. 121(2):430–5.
Article
22. Galetke W, Anduleit N, Richter K, Stieglitz S, Randerath WJ. Comparison of automatic and continuous positive airway pressure in a night-by-night analysis: a randomized, crossover study. Respiration. 2008; Mar. 75(2):163–9.
Article
23. Mulgrew AT, Cheema R, Fleetham J, Ryan CF, Ayas NT. Efficacy and patient satisfaction with autoadjusting CPAP with variable expiratory pressure vs standard CPAP: a two-night randomized crossover trial. Sleep Breath. 2007; Mar. 11(1):31–7.
Article
24. Randerath WJ, Schraeder O, Galetke W, Feldmeyer F, Ruhle KH. Autoadjusting CPAP therapy based on impedance efficacy, compliance and acceptance. Am J Respir Crit Care Med. 2001; Mar. 163(3 Pt 1):652–7.
Article
25. Rafael-Palou X, Turino C, Steblin A, Sanchez-de-la-Torre M, Barbe F, Vargiu E. Comparative analysis of predictive methods for early assessment of compliance with continuous positive airway pressure therapy. BMC Med Inform Decis Mak. 2018; Sep. 18(1):81.
Article
26. Campos-Rodriguez F, Martinez-Garcia MA, Reyes-Nunez N, Caballero-Martinez I, Almeida-Gonzalez CV, Catalan-Serra P, et al. Longterm continuous positive airway pressure compliance in females with obstructive sleep apnoea. Eur Respir J. 2013; Nov. 42(5):1255–62.
Article
27. Wohlgemuth WK, Chirinos DA, Domingo S, Wallace DM. Attempters, adherers, and non-adherers: latent profile analysis of CPAP use with correlates. Sleep Med. 2015; Mar. 16(3):336–42.
Article
28. Means MK, Edinger JD, Husain AM. CPAP compliance in sleep apnea patients with and without laboratory CPAP titration. Sleep Breath. 2004; Mar. 8(1):7–14.
Article
29. Lee CH, Leow LC, Song PR, Li H, Ong TH. Acceptance and adherence to continuous positive airway pressure therapy in patients with obstructive sleep apnea (OSA) in a Southeast Asian privately funded healthcare system. Sleep Sci. 2017; Apr-Jun. 10(2):57–63.
Article
30. Pandey A, Mereddy S, Combs D, Shetty S, Patel SI, Mashaq S, et al. Socioeconomic inequities in adherence to positive airway pressure therapy in population-level analysis. J Clin Med. 2020; Feb. 9(2):442.
Article
Full Text Links
  • CEO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr